<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:department>Sch of Chemistry</gtr:department><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/2DB7ED73-8E89-457A-A395-FAC12F929C1A"><gtr:id>2DB7ED73-8E89-457A-A395-FAC12F929C1A</gtr:id><gtr:name>University of Edinburgh</gtr:name><gtr:address><gtr:line1>Old College</gtr:line1><gtr:line2>South Bridge</gtr:line2><gtr:line3>Mayfield Road</gtr:line3><gtr:line4>Edinburgh</gtr:line4><gtr:postCode>EH8 9YL</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7BC6FCF2-358C-45C5-A5A7-E859DD754711"><gtr:id>7BC6FCF2-358C-45C5-A5A7-E859DD754711</gtr:id><gtr:name>Lund University</gtr:name><gtr:address><gtr:line1>Box 117</gtr:line1><gtr:line2>S-221 00</gtr:line2><gtr:line4>Lund</gtr:line4><gtr:postCode>S-221 00</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Sweden</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/3B1E5961-8677-4A32-B15C-12FB968FA163"><gtr:id>3B1E5961-8677-4A32-B15C-12FB968FA163</gtr:id><gtr:name>University of Pennsylvania</gtr:name><gtr:address><gtr:line1>3451 Walnut Street,</gtr:line1><gtr:line2>Suite P-221</gtr:line2><gtr:line3>Franklin Building</gtr:line3><gtr:line4>Philadelphia</gtr:line4><gtr:postCode>PA 19104</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>United States</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/5E2B04DD-4A03-45ED-9892-61C5CCB8AC68"><gtr:id>5E2B04DD-4A03-45ED-9892-61C5CCB8AC68</gtr:id><gtr:name>Newcastle University</gtr:name><gtr:address><gtr:line1>1 Park Terrace</gtr:line1><gtr:line4>Newcastle Upon Tyne</gtr:line4><gtr:line5>Tyne and Wear</gtr:line5><gtr:postCode>NE1 7RU</gtr:postCode><gtr:region>North East</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/B9A0B36E-D18D-40A3-AF66-0918CDD0B776"><gtr:id>B9A0B36E-D18D-40A3-AF66-0918CDD0B776</gtr:id><gtr:firstName>Paul</gtr:firstName><gtr:otherNames>Nigel</gtr:otherNames><gtr:surname>Barlow</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0001089"><gtr:id>66CB0696-F738-4139-B9F7-040E24AC9BA8</gtr:id><gtr:title>Structural Biology of Fluid-Phase Regulators of Complement Activation &amp;amp; Mechanisms for Evasion of Complement by Pathogen</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0001089</gtr:grantReference><gtr:abstractText>Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.</gtr:abstractText><gtr:fund><gtr:end>2006-11-30</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2001-12-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>766801</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Queen's Medical Research Institute Edinburgh</gtr:department><gtr:description>Partnership for new anticomplement therapies</gtr:description><gtr:id>950F0768-DE43-455D-886C-551591A7BD8E</gtr:id><gtr:impact>Patent filing and paper 21146613
Research grant funding from Chief Scientist's Office (Scotland)
Joint studentship funding (Heather Kerr)</gtr:impact><gtr:outcomeId>0C214EB86C3-2</gtr:outcomeId><gtr:partnerContribution>Better understanding of potential for anticomplement therapies. Avenues for testing therapeutics in mouse models</gtr:partnerContribution><gtr:piContribution>Contribution of intellectual material and development of new methodologies</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Edinburgh</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Centre for Inflammation Research</gtr:department><gtr:description>Partnership for new anticomplement therapies</gtr:description><gtr:id>14840901-52E2-4164-A0A8-034A266C4C98</gtr:id><gtr:impact>Patent filing and paper 21146613
Research grant funding from Chief Scientist's Office (Scotland)
Joint studentship funding (Heather Kerr)</gtr:impact><gtr:outcomeId>0C214EB86C3-1</gtr:outcomeId><gtr:partnerContribution>Better understanding of potential for anticomplement therapies. Avenues for testing therapeutics in mouse models</gtr:partnerContribution><gtr:piContribution>Contribution of intellectual material and development of new methodologies</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2009-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Pennsylvania</gtr:collaboratingOrganisation><gtr:country>United States of America</gtr:country><gtr:description>Collaboration on staphylococcal complement inhibitor</gtr:description><gtr:id>00E140A3-D726-44CA-BD70-30359F5E9020</gtr:id><gtr:impact>Paper PMID 19625656</gtr:impact><gtr:outcomeId>B6C92DEEEE1-1</gtr:outcomeId><gtr:partnerContribution>Better understanding of complement</gtr:partnerContribution><gtr:piContribution>Supplied reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Newcastle University</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>School of Clinical and Laboratory sciences</gtr:department><gtr:description>Parnership with Tim Goodship</gtr:description><gtr:id>A096015B-C31E-4A06-87F5-EAF4BA77C06B</gtr:id><gtr:impact>Paper PMID 19861685 and PMID 20592223
and PMID 22721707</gtr:impact><gtr:outcomeId>74D81EC24EF-1</gtr:outcomeId><gtr:partnerContribution>Insights into role of factor H in disease</gtr:partnerContribution><gtr:piContribution>Supplied reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Lund University</gtr:collaboratingOrganisation><gtr:country>Sweden, Kingdom of</gtr:country><gtr:description>Collaboration with Lund Immunochemistry</gtr:description><gtr:id>03F01944-FAA5-4F33-AE31-555B23F165CB</gtr:id><gtr:impact>Papers PMID 19951950 and 18715646</gtr:impact><gtr:outcomeId>379713848F1-1</gtr:outcomeId><gtr:partnerContribution>Better understanding of factor H biology</gtr:partnerContribution><gtr:piContribution>Contribution of molecular models and reagents</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Press release AMD</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>11F7F376-069F-43D9-8BB6-4BD9EF25E69A</gtr:id><gtr:impact>Articles in Daily Telegraph and BBC online plus local newspapers

Received letters from AMD sufferers asking to participate in clinical trials etc.</gtr:impact><gtr:outcomeId>9AB37D35FC0</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2007</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>CCP module page</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E367730C-1615-499D-8B76-302438DA6095</gtr:id><gtr:impact>web-based resource on CCP modules

site visited several dozen times per month</gtr:impact><gtr:outcomeId>39B83C5A849</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2006,2007,2008,2009,2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Dense Deposit Group</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>76E4B9CD-78D7-4A91-AD47-E38BCDAFC573</gtr:id><gtr:impact>Two-day discussion on therapies for DDD

New clinical trial under orphan drug status to be established</gtr:impact><gtr:outcomeId>971FF1418F4</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Paper Presentation</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:year>2008,2010</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>10000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Pathfinder - for market analysis</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:fundingRef>BB/FOF/PF/2/13</gtr:fundingRef><gtr:id>F30C0EE5-3AE7-4B0A-B5A0-164BC94EC668</gtr:id><gtr:outcomeId>smx5o6DeWWq</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-08-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>15000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Sparking Impact</gtr:description><gtr:end>2013-12-02</gtr:end><gtr:fundingOrg>Biotechnology and Biological Sciences Research Council (BBSRC)</gtr:fundingOrg><gtr:id>19F3F537-1648-4EB4-8E46-0B1C019C3727</gtr:id><gtr:outcomeId>JDvjQdv9QDQ</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2013-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>75000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>CSO funding (Formulation of anticomplement therapy)</gtr:description><gtr:end>2011-11-02</gtr:end><gtr:fundingOrg>Chief Scientist Office (CSO)</gtr:fundingOrg><gtr:id>912097EA-61EE-4328-B398-72CDFA6D090A</gtr:id><gtr:outcomeId>837FD2F03D10</gtr:outcomeId><gtr:sector>Public</gtr:sector><gtr:start>2010-12-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>550000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Structure-function of factor H</gtr:description><gtr:end>2012-12-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>26654B86-769E-4EEE-BCB9-9C446A710BD3</gtr:id><gtr:outcomeId>AD75F31C3800</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-05-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>treatment of aHUS</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>108C6FF5-760D-4AC1-91DE-40BEB3C14323</gtr:id><gtr:impact>We played a tiny part in policies emanating from Newcastle University (Tim Goodship) on kidney transplants in aHUS/DDD and contributed to paper PMID 17675665</gtr:impact><gtr:outcomeId>1558A54634A</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type><gtr:url>http://europepmc.org/abstract/MED/17675665</gtr:url></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs><gtr:productOutput><gtr:description>Recombinant factor H - details under previous section (on IPR)</gtr:description><gtr:id>85AC57C6-FDFD-4E7A-A1EB-41FF811533C4</gtr:id><gtr:impact>Please see previous sections (on IPR)</gtr:impact><gtr:outcomeId>32055AEF780</gtr:outcomeId><gtr:stage>Initial development</gtr:stage><gtr:status>Actively seeking support</gtr:status><gtr:title>anticomplement</gtr:title><gtr:type>Therapeutic Intervention - Drug</gtr:type><gtr:yearDevCompleted>2009</gtr:yearDevCompleted></gtr:productOutput></gtr:productOutputs><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>structural coordinates</gtr:description><gtr:id>5D8E8769-725B-4404-88D8-DBCA6E6D4B65</gtr:id><gtr:impact>Frequently cited and used for modelling etc.</gtr:impact><gtr:outcomeId>62542793D88</gtr:outcomeId><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>structures of factor H fragments</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>A library of factor h fragments</gtr:description><gtr:id>D3F07278-F81B-4A30-B575-D8A642C58261</gtr:id><gtr:impact>We receive numerous requests for our fragments from around the world - resulted in collaborations and joint publications</gtr:impact><gtr:outcomeId>FF5DFB9C590</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Factor H fragment library</gtr:title><gtr:type>Database/Collection of Data/Biological Samples</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>35FF3F6B-60E8-4625-A92A-6CD6B0D31471</gtr:id><gtr:title>The binding of factor H to a complex of physiological polyanions and C3b on cells is impaired in atypical hemolytic uremic syndrome.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b8ac306f4965eec3666e5fa44510989"><gtr:id>4b8ac306f4965eec3666e5fa44510989</gtr:id><gtr:otherNames>Ferreira VP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>342B312180C</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>28297A10-8947-4DE7-ADC0-22D76C984C76</gtr:id><gtr:title>Disease-associated sequence variations in factor H: a structural biology approach.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d51ddea33c74777c1686c55b26873b9e"><gtr:id>d51ddea33c74777c1686c55b26873b9e</gtr:id><gtr:otherNames>Herbert AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>94CB0CB0DB2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>056C12AC-2962-4355-A87C-4335FD21247B</gtr:id><gtr:title>Critical role of the C-terminal domains of factor H in regulating complement activation at cell surfaces.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4b8ac306f4965eec3666e5fa44510989"><gtr:id>4b8ac306f4965eec3666e5fa44510989</gtr:id><gtr:otherNames>Ferreira VP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>50D8887A26D</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2D32DEA6-1431-424C-9845-DD2BA576C29B</gtr:id><gtr:title>Disease-associated sequence variations congregate in a polyanion recognition patch on human factor H revealed in three-dimensional structure.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d51ddea33c74777c1686c55b26873b9e"><gtr:id>d51ddea33c74777c1686c55b26873b9e</gtr:id><gtr:otherNames>Herbert AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2006-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>A6E72A702BB</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>C598BBCF-BA0B-460A-AEEE-E142CFF62AF9</gtr:id><gtr:title>Annexin-II, DNA, and histones serve as factor H ligands on the surface of apoptotic cells.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c81e2c2923691f3e0c305dc1f3237db5"><gtr:id>c81e2c2923691f3e0c305dc1f3237db5</gtr:id><gtr:otherNames>Leffler J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>dymjBaYkPBV</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>43A7ABF4-ED63-4D2D-872C-07EE5A2DD406</gtr:id><gtr:title>Structure shows that a glycosaminoglycan and protein recognition site in factor H is perturbed by age-related macular degeneration-linked single nucleotide polymorphism.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d51ddea33c74777c1686c55b26873b9e"><gtr:id>d51ddea33c74777c1686c55b26873b9e</gtr:id><gtr:otherNames>Herbert AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>862CFAA1EE2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>70E29357-00F2-4545-905A-3894F71069AC</gtr:id><gtr:title>Complement factor H: using atomic resolution structure to illuminate disease mechanisms.</gtr:title><gtr:parentPublicationTitle>Advances in experimental medicine and biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8ecc79cfc55792f83c7640de77499f83"><gtr:id>8ecc79cfc55792f83c7640de77499f83</gtr:id><gtr:otherNames>Barlow PN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0065-2598</gtr:issn><gtr:outcomeId>568DA7DD995</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>924375E8-7135-4384-A691-1D88AFF0A325</gtr:id><gtr:title>Structural analysis of the C-terminal region (modules 18-20) of complement regulator factor H (FH).</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c0a728694ce56c7a4de665db1124c41"><gtr:id>0c0a728694ce56c7a4de665db1124c41</gtr:id><gtr:otherNames>Morgan HP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_16512_22_22389686</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>5430E947-9D87-4576-8DE9-15AC2DCEC3F8</gtr:id><gtr:title>Structural basis and functional effects of the interaction between complement inhibitor C4b-binding protein and DNA.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0bb19d77ca779371ac372d3b6ec47e3e"><gtr:id>0bb19d77ca779371ac372d3b6ec47e3e</gtr:id><gtr:otherNames>Okroj M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn><gtr:outcomeId>68D231CE7DD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>646DC218-6C1F-4F46-8590-1AC47131D3D0</gtr:id><gtr:title>Structure-based mapping of DAF active site residues that accelerate the decay of C3 convertases.</gtr:title><gtr:parentPublicationTitle>The Journal of biological chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/befd44b965bdb7dba720510c7cf6bf7b"><gtr:id>befd44b965bdb7dba720510c7cf6bf7b</gtr:id><gtr:otherNames>Kuttner-Kondo L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0021-9258</gtr:issn><gtr:outcomeId>D2047FEA184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>455F5B4D-87BD-43AC-B57B-14226441F6B4</gtr:id><gtr:title>Structural basis for complement factor H linked age-related macular degeneration.</gtr:title><gtr:parentPublicationTitle>The Journal of experimental medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4cdcec230a94890850216015cb900500"><gtr:id>4cdcec230a94890850216015cb900500</gtr:id><gtr:otherNames>Prosser BE</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0022-1007</gtr:issn><gtr:outcomeId>D0965CB7040</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8C2945D0-4C69-4CB3-AB62-4D6AA094B5D1</gtr:id><gtr:title>A molecular insight into complement evasion by the staphylococcal complement inhibitor protein family.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/01b177d2fefa312445c8e3be1f73e6b4"><gtr:id>01b177d2fefa312445c8e3be1f73e6b4</gtr:id><gtr:otherNames>Ricklin D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>C07BF9F2D84</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3C2EA650-750E-4807-9637-ED0ED0D86CBB</gtr:id><gtr:title>Functional anatomy of complement factor H.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c54395becaa59e5d097298e33fa415f"><gtr:id>0c54395becaa59e5d097298e33fa415f</gtr:id><gtr:otherNames>Makou E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>pm_16512_22_23701234</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>336658E3-D5E2-4DF1-B2B7-7D3D22A20D0C</gtr:id><gtr:title>Structural basis for engagement by complement factor H of C3b on a self surface.</gtr:title><gtr:parentPublicationTitle>Nature structural &amp; molecular biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0c0a728694ce56c7a4de665db1124c41"><gtr:id>0c0a728694ce56c7a4de665db1124c41</gtr:id><gtr:otherNames>Morgan HP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1545-9985</gtr:issn><gtr:outcomeId>eTRz6pwRvpH</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AAEDEA4D-E443-4B18-BE1E-20026CE851A7</gtr:id><gtr:title>Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.</gtr:title><gtr:parentPublicationTitle>Blood</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0ed8c05a2eb8a6b16f7af589920e6999"><gtr:id>0ed8c05a2eb8a6b16f7af589920e6999</gtr:id><gtr:otherNames>Moore I</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0006-4971</gtr:issn><gtr:outcomeId>dsxAo9EDiCp</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>86F52A8A-F634-4EA3-BCA4-A43B4AA7C3B5</gtr:id><gtr:title>Structural and functional characterization of the product of disease-related factor H gene conversion.</gtr:title><gtr:parentPublicationTitle>Biochemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d51ddea33c74777c1686c55b26873b9e"><gtr:id>d51ddea33c74777c1686c55b26873b9e</gtr:id><gtr:otherNames>Herbert AP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0006-2960</gtr:issn><gtr:outcomeId>pm_16512_22_22320225</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9EC7EBC5-0474-4A97-BC61-D1A232804C60</gtr:id><gtr:title>Translational mini-review series on complement factor H: structural and functional correlations for factor H.</gtr:title><gtr:parentPublicationTitle>Clinical and experimental immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/522860572a4c00a3269e69e9128981a8"><gtr:id>522860572a4c00a3269e69e9128981a8</gtr:id><gtr:otherNames>Schmidt CQ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0009-9104</gtr:issn><gtr:outcomeId>FEF886B917B</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>828EC023-157A-4986-9691-C7279A9DD5C9</gtr:id><gtr:title>New approaches to the treatment of dense deposit disease.</gtr:title><gtr:parentPublicationTitle>Journal of the American Society of Nephrology : JASN</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f7bdd0fe9638ad615fda1b25f1524a99"><gtr:id>f7bdd0fe9638ad615fda1b25f1524a99</gtr:id><gtr:otherNames>Smith RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1046-6673</gtr:issn><gtr:outcomeId>A926158786A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>01148417-83F3-4A4F-8111-7DFEC8EF10B6</gtr:id><gtr:title>Deciphering complement mechanisms: the contributions of structural biology.</gtr:title><gtr:parentPublicationTitle>Molecular immunology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7e25bf616e4fadd42dac345bb65e5665"><gtr:id>7e25bf616e4fadd42dac345bb65e5665</gtr:id><gtr:otherNames>Arlaud GJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0161-5890</gtr:issn><gtr:outcomeId>F6D0ED1C80F</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>801E440E-2E28-40D6-A23E-A6FB65388DD9</gtr:id><gtr:title>Complement factor h autoantibodies and age-related macular degeneration.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/997fac510f4db4c753fc4e05f129ad0e"><gtr:id>997fac510f4db4c753fc4e05f129ad0e</gtr:id><gtr:otherNames>Dhillon B</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>hb1GzW6DaGW</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0001089</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory><gtr:healthCategory><gtr:id>C6D70A71-8796-47BC-AFE0-CC2286E66A06</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>Inflammatory and Immune System</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>50</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>